利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

41 条记录 (耗时 0.05 秒)

    Retail Product Display System With A Drawer Provided With A Movable Demonstration Product Locator At Its Front
    1.
    发明申请
    Retail Product Display System With A Drawer Provided With A Movable Demonstration Product Locator At Its Front 有权
    零售产品展示系统，带有可移动演示产品定位器的抽屉

    公开(公告)号：US20120280600A1

    公开(公告)日：2012-11-08

    申请号：US13395524

    申请日：2010-09-17

    申请人： Harold Noel ,  Fabien Brossard ,  Patrick Ple-Boishardy

    发明人： Harold Noel ,  Fabien Brossard ,  Patrick Ple-Boishardy

    IPC分类号： A47F3/00 ,  A47F5/00

    CPC分类号： A47F7/286

    摘要： A retail product display system 72, comprising a retail product drawer 20 slideable between a closed position and an open position, a demonstration product locator 30 arranged at the front of the retail product drawer 20 and movable between two extreme positions respectively an inclined display position and a horizontal display position, wherein the system is arranged for allowing the demonstration product locator 30 to be in the inclined display position when the retail product drawer 20 is in the closed position and for allowing the demonstration product locator 30 to be in the horizontal display position when the retail product drawer 20 is in the open position.The invention makes it possible to offer greater space for accommodating demonstration products or displaying information with easy access to the retail product for purchase by the customer.

    摘要翻译： 一种零售产品展示系统72，包括可在关闭位置和打开位置之间滑动的零售商品抽屉20，布置在零售产品抽屉20的前部的演示产品定位器30，分别可在两个极限位置之间移动倾斜显示位置和 水平显示位置，其中系统被布置成当零售产品抽屉20处于关闭位置时允许演示产品定位器30处于倾斜显示位置，并且允许演示产品定位器30处于水平显示位置 当零售产品抽屉20处于打开位置时。 本发明使得可以提供更大的空间用于容纳示范产品或显示信息，容易地访问零售商品以供客户购买。

    Oxime derivatives
    6.
    发明授权
    Oxime derivatives 失效
    肟衍生物

    公开(公告)号：US5482966A

    公开(公告)日：1996-01-09

    申请号：US240464

    申请日：1994-06-13

    申请人： Thomas G. C. Bird ,  Patrick Ple

    发明人： Thomas G. C. Bird ,  Patrick Ple

    IPC分类号： A61K31/425 ,  A61K31/505 ,  A61P29/00 ,  A61P37/08 ,  A61P43/00 ,  C07D239/42 ,  C07D307/20 ,  C07D309/08 ,  C07D309/10 ,  C07D317/22 ,  C07D405/04 ,  C07D409/02 ,  C07D409/04 ,  C07D409/12 ,  C07D417/04 ,  C07D417/12 ,  A61K31/35 ,  A61K31/34

    CPC分类号： C07D405/04 ,  C07D307/20 ,  C07D309/10 ,  C07D317/22 ,  C07D409/04 ,  C07D417/04

    摘要： The invention concerns oxime derivatives of the formula I ##STR1## wherein R.sup.4 includes hydrogen, carboxy, carbamoyl, amino, cyano, trifluoromethyl, (1-4C)alkylamino, di-(1-4C)alkylamino and (1-4C)alkyl;R.sup.5 includes hydrogen, (1-4C)alkyl, (3-4C)alkenyl, (3-4C)alkynyl, (2-5C)alkanoyl, halogeno-(2-4C)alkyl and hydroxy-(2-4C)alkyl;Ar.sup.1 is phenylene or a heteroaryl diradical;A.sup.1 is a direct link to X.sup.1, or A.sup.1 is (1-4C)alkylene;X.sup.1 is oxy, thio, sulphinyl or sulphonyl;Ar.sup.2 is phenylene or a heteroaryl diradical;R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; andR.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which together with the carbon atom to which A.sup.2 and A.sup.3 are attached define a ring having 5 or 6 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl, sulphonyl or imino;or a pharmaceutically-acceptable salt thereof;processes for their manufacture; pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors.

    摘要翻译： 本发明涉及式I的肟衍生物，其中R 4包括氢，羧基，氨基甲酰基，氨基，氰基，三氟甲基，（1-4C）烷基氨基，二（1-4C）烷基氨基和（1-4C）烷基 ; R5包括氢，（1-4C）烷基，（3-4C）烯基，（3-4C）炔基，（2-5C）烷酰基，卤代 - （2-4C）烷基和羟基 - （2-4C）烷基; Ar1是亚苯基或杂芳基双基; A1是直接连接到X1，或A1是（1-4C）亚烷基; X1是氧基，硫基，亚磺酰基或磺酰基; Ar 2是亚苯基或杂芳基双基; R1是（1-4C）烷基，（3-4C）烯基或（3-4C）炔基; 并且R2和R3一起形成式-A2-X2-A3-的基团，其与A2和A3所连接的碳原子一起形成具有5或6个环原子的环，其中A2和A3各自为（1 -3C）亚烷基，X 2为氧基，硫基，亚磺酰基，磺酰基或亚氨基; 或其药学上可接受的盐; 制造过程; 含有它们的药物组合物及其作为5-脂肪氧合酶抑制剂的用途。

    Quinoline derivatives
    8.
    发明授权
    Quinoline derivatives 失效
    喹啉衍生物

    公开(公告)号：US07973164B2

    公开(公告)日：2011-07-05

    申请号：US12280848

    申请日：2007-03-01

    申请人： Frederic Henri Jung ,  Patrick Ple

    发明人： Frederic Henri Jung ,  Patrick Ple

    IPC分类号： C07D215/38

    CPC分类号： C07D401/12 ,  C07D215/233

    摘要： The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

    摘要翻译： 本发明涉及式I的喹啉衍生物或其药学上可接受的盐，其中X 1，p，R 1，q，R 2，R 3，R 4，R 5，环A，r和R 6中的每一个在 描述; 其制备方法，含有它们的药物组合物及其在制备用于治疗细胞增殖性疾病的药物中的用途。

    Quinazoline derivatives for use against cancer
    9.
    发明申请
    Quinazoline derivatives for use against cancer 审中-公开
    用于抗癌的喹唑啉衍生物

    公开(公告)号：US20090036474A1

    公开(公告)日：2009-02-05

    申请号：US11665115

    申请日：2005-10-07

    申请人： Patrick Ple ,  Frederic Henri Jung

    发明人： Patrick Ple ,  Frederic Henri Jung

    IPC分类号： A61K31/517 ,  C07D403/12 ,  A61P9/00

    CPC分类号： C07D417/14 ,  C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/14

    摘要： The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of p, R1, q, R2, R3, R4, R5, Ring A, X1, R6, r and R7 has any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.

    摘要翻译： 本发明涉及式（I）的喹唑啉衍生物或其药学上可接受的盐，溶剂化物或前体药物，其中p，R1，q，R2，R3，R4，R5，环A，X1，R6，r和 R7具有描述中定义的任何含义; 其制备方法，含有它们的药物组合物及其在制备用于治疗细胞增殖性疾病或治疗与血管生成和/或血管通透性相关的疾病状态的药物中的用途。